Login / Signup

Letter: Experience of switching vedolizumab treatment from intravenous to subcutaneous formulation in Hungary.

Péter BacsurÁkos IliásTamás ResálDiána KataTamás MolnárKlaudia Farkas
Published in: Alimentary pharmacology & therapeutics (2023)
Keyphrases
  • drug delivery
  • high dose
  • ulcerative colitis
  • combination therapy
  • replacement therapy